Company Swedencare AB (publ) Nasdaq Stockholm
Equities
SE0008294078
Pharmaceuticals
Business Summary
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Nutraceuticals
53.3
%
| 917 | 50.1 % | 1,240 | 53.3 % | +35.25% |
Topicals/Dermatology
23.9
%
| 563 | 30.8 % | 556 | 23.9 % | -1.34% |
ProDen PlaqueOff
11.6
%
| 179 | 9.8 % | 270 | 11.6 % | +50.51% |
Other
7.0
%
| 79 | 4.3 % | 163 | 7.0 % | +107.21% |
Pharma
4.2
%
| 92 | 5.0 % | 97 | 4.2 % | +5.29% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
North America
78.6
%
| 1,479 | 80.9 % | 1,827 | 78.6 % | +23.50% |
Europe
18.6
%
| 173 | 9.5 % | 432 | 18.6 % | +149.51% |
Rest of the World
2.8
%
| 7 | 0.4 % | 65 | 2.8 % | +798.72% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 31/12/13 | |
Jenny Graflind
DFI | Director of Finance/CFO | 48 | 31/12/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | 31/12/22 | |
Director/Board Member | 57 | 31/12/15 | |
Director/Board Member | 61 | 31/12/18 | |
Chief Executive Officer | 56 | 31/12/13 | |
Chairman | 67 | 28/02/14 | |
Director/Board Member | 60 | 31/12/21 | |
Director/Board Member | 57 | 31/12/21 | |
Johan Bergdahl
BRD | Director/Board Member | 54 | 31/12/13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 158,731,900 | 48,338,470 ( 30.45 %) | 0 | 30.45 % |
Company contact information
![address Swedencare AB (publ)](https://cdn.zonebourse.com/static/address/38588329.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-12.16% | 79.1B | |
-3.15% | 7.13B | |
+21.25% | 3.58B | |
-9.18% | 2.93B | |
+16.05% | 1.69B | |
-8.50% | 1.19B | |
-33.05% | 1.11B | |
-36.85% | 1.05B | |
-27.92% | 939M |